Design Therapeutics, Inc. DSGN Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s total liabilities?
- Design Therapeutics, Inc. (DSGN) reported total liabilities of $12.39M in Q1 2026.
- How has Design Therapeutics, Inc.'s total liabilities changed year-over-year?
- Design Therapeutics, Inc.'s total liabilities increased by 29.6% year-over-year, from $9.56M to $12.39M.
- What is the long-term trend for Design Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total liabilities has grown at a 40.8% compound annual growth rate (CAGR), from $2.48M to $13.7M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.